The La (SS-B) antigen

  • Ger J. M. Pruijn
Chapter

Key words

Autoantigen Ribonucleoprotein La (SS-B) Sjögren’s syndrome systemic lupus erythematosus 

Abbreviations

aa

amino acids

bLa

bovine La (SS-B)

cDNA

complementary DNA

CIE

counterimmunoelectrophoresis

ELISA

enzyme-linked immunosorbant assay

hLa

human La (SS-B)

IB

immunoblotting

ID

immunodiffusion

IF

immunofluorescence

IP

imunoprecipitation

kb

kilo basepairs

mLa

mouse La (SS-B)

NLS

nuclear localization signal

NP-40

Nonident P-40

PKR

double-stranded RNA-activated protein kinase

rabLa

rabbit La (SS-B)

rLa

rat La(SS-B)

RNP

ribonucleoprotein particle

rRNA

ribosomal RNA

SDS

sodium dodecyl sulphate

SLE

systemic lupus erythematosus

snRNA

small nuclear RNA

tRNA

transfer RNA

xLaA

Xenopus Laevis La (SS-B), variant A

xLaB

Xenopus Laevis La (SS-B), variant B

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Anderson JR, Gray KG, Beck JS & Kinnear WF (1961) Lancet 2:456–460PubMedCrossRefGoogle Scholar
  2. 2.
    Clark G, Reichlin M & Tomasi TB (1969) J Immunol 102:117–122PubMedGoogle Scholar
  3. 3.
    Alspaugh MA & Tan EM (1975) J Clin Invest 55:1067–1073PubMedCrossRefGoogle Scholar
  4. 4.
    Alspaugh MA & Maddison P (1979) Arthritis Rheum 22:796–798PubMedCrossRefGoogle Scholar
  5. 5.
    Lerner MR, Boyle JA, Hardin JA & Steitz JA (1981) Science 211:400–402PubMedCrossRefGoogle Scholar
  6. 6.
    Slobbe RL, Pruijn GJM & van Venrooij WJ (1991) Ann Med Interne (Paris) 142:592–600Google Scholar
  7. 7.
    Ben-Chetrit E (1993) Br J Rheumatol 32:396–402PubMedCrossRefGoogle Scholar
  8. 8.
    Chan EKL & Andrade LEC (1992) Rheum Dis Clin North Am 18:551–570PubMedGoogle Scholar
  9. 9.
    Reichlin M (1992) In: Lahita R (Ed) Systemic Lupus Erythematosus. Antibodies to Cytoplasmic Antigens (pp 237–246). Churchill Livingstone, New YorkGoogle Scholar
  10. 10.
    van Venrooij WJ, Slobbe RL & Pruijn GJM (1993) Mol Biol Reports 18:113–119CrossRefGoogle Scholar
  11. 11.
    McCauliffe DP, Lux FA, Lieu TS, Sanz I, Hanke J, Newkirk MM, Bachinski LL, Itoh Y, Siciliano MJ, Reichlin M, Sontheimer RD & Capra JD (1990) J Clin Invest 85:1379–1391PubMedCrossRefGoogle Scholar
  12. 12.
    McCauliffe DP, Zappi E, Lieu TS, Michalak M, Sontheimer RD & Capra JD (1990) J Clin Invest 86:332–335CrossRefGoogle Scholar
  13. 13.
    Rokeach LA, Haselby JA, Meilof JF, Smeenk RJT, Unnasch TR, Greene BM & Hoch SO (1991) J Immunol 147:3031–3039PubMedGoogle Scholar
  14. 14.
    Ben-Chetrit E, Chan EKL, Sullivan KF & Tan EM (1988) J Exp Med 167:1560–1571PubMedCrossRefGoogle Scholar
  15. 15.
    Rader MD, O’Brien C, Liu YS, Harley JB & Reichlin M (1989) J Clin Invest 83:1293–1298PubMedCrossRefGoogle Scholar
  16. 16.
    Hendrick JP, Wolin SL, Rinke J, Lerner MR & Steitz JA (1981) Mol Cell Biol 1:1138–1149PubMedGoogle Scholar
  17. 17.
    Wolin SL & Steitz JA (1984) Proc Natl Acad Sci USA 81:1996–2000PubMedCrossRefGoogle Scholar
  18. 18.
    Pruijn GJM, Slobbe RL & van Venrooij WJ (1991) Nucleic Acids Res 19:5173–5180PubMedCrossRefGoogle Scholar
  19. 19.
    Slobbe RL, Pluk W, van Venrooij WJ & Pruijn GJM (1992) J Mol Biol 227:361–366PubMedCrossRefGoogle Scholar
  20. 20.
    Deutscher SL, Harley JB & Keene JD (1988) Proc Natl Acad Sci USA 85:9479–9483PubMedCrossRefGoogle Scholar
  21. 21.
    Mamula MJ, Silverman ED, Laxer RM, Bentur L, Isacovics B & Hardin JA (1989) J Immunol 143:2923–2928Google Scholar
  22. 22.
    Boire G & Craft J (1990) J Clin Invest 85:1182–1190CrossRefGoogle Scholar
  23. 23.
    Harmon CE, Deng JS, Peebles CL & Tan EM (1984) Arthritis Rheum 27:166–173PubMedCrossRefGoogle Scholar
  24. 24.
    Itoh Y, Kriet JD & Reichlin M (1990) Arthritis Rheum 33:1815–1821PubMedCrossRefGoogle Scholar
  25. 25.
    Takano S, Matsushima H, Hiwatashi T & Miyachi K (1989) Jpn J Rheumatol 2:67–78Google Scholar
  26. 26.
    Manoussakis MN, Kistis KG, Liu X, Aidinis V, Guialis A & Moutsopoulos HM (1993) Br J Rheumatol 32:449–455PubMedCrossRefGoogle Scholar
  27. 27.
    Meilof JF, Bantjes I, De Jong J, Van Dam AP & Smeenk RJ (1990) J Immunol Methods 133:215–226PubMedCrossRefGoogle Scholar
  28. 28.
    Chan EKL & Pollard KM (1992) In: Rose NR, Conway de Macario E, Fahey JL, Friedman H & Penn GM (Eds) Manual of Clinical Laboratory Immunology. Antibodies to Ribonucleoprotein Particles by Immunoblotting (pp 755–761). American Society of Microbiology, Washington, DCGoogle Scholar
  29. 29.
    Buyon JP, Slade SG, Chan EKL, Tan EM & Winchester R (1990) J Immunol Methods 129:207–210PubMedCrossRefGoogle Scholar
  30. 30.
    Slobbe RL, Pruijn GJM, Damen WG, van der Kemp JW & van Venrooij WJ (1991) Clin Exp Immunol 86:99–105CrossRefGoogle Scholar
  31. 31.
    Forman MS, Nakamura M, Mimori T, Gelpi C & Hardin JA (1985) Arthritis Rheum 28:1356–1361PubMedCrossRefGoogle Scholar
  32. 32.
    Boire G & Craft J (1989) J Clin Invest 84:270–279CrossRefGoogle Scholar
  33. 33.
    Boire G, Lopez-Longo F-J, Lapointe S & Menard HA (1991) Arthritis Rheum 34:722–730PubMedCrossRefGoogle Scholar
  34. 34.
    Tsuzaka K, Fujii T, Akizuki M, Mimori T, Tojo T, Fujii H, Tsukatani Y, Kubo A & Homma M (1994) Arthritis Rheum 37:88–92PubMedCrossRefGoogle Scholar
  35. 35.
    Chan EKL, Hamel JC, Buyon JP & Tan EM (1991) J Clin Invest 87:68–76PubMedCrossRefGoogle Scholar
  36. 36.
    Yamagata H, Harley JB & Reichlin M (1984) J Clin Invest 74:625–633CrossRefGoogle Scholar
  37. 37.
    Kumagai T (1991) Jpn J Rheumatol 3:137–150Google Scholar
  38. 38.
    Julkunen H, Kurki P, Kaaja R, Heikkila R, Immonen I, Chan EKL, Wallgren E & Friman C (1993) Arthritis Rheum 36:1588–1598PubMedCrossRefGoogle Scholar
  39. 39.
    Alspaugh MA, Talal N & Tan EM (1976) Arthritis Rheum 19:216–222PubMedCrossRefGoogle Scholar
  40. 40.
    Wolin SL & Steitz JA (1983) Cell 32:735–744PubMedCrossRefGoogle Scholar
  41. 41.
    Itoh K, Itoh Y & Frank MB (1991) J Clin Invest 87:177–186CrossRefGoogle Scholar
  42. 42.
    Mamula MJ, Obrien CA, Harley JB & Hardin JA (1989) Clin Immunol Immunopathol 52:435–446PubMedCrossRefGoogle Scholar
  43. 43.
    O’Brien CA, Margelot K & Wolin SL (1993) Proc Natl Acad Sci USA 90:7250–7254PubMedCrossRefGoogle Scholar
  44. 44.
    Peek R, Pruijn GJM, van der Kemp AJW & van Venrooij WJ (1993) J Cell Sci 106:929–935PubMedGoogle Scholar
  45. 45.
    O’Brien CA & Harley JB (1990) EMBO J 9:3683–3689PubMedGoogle Scholar
  46. 46.
    Itoh Y & Reichlin M (1991) Arthritis Rheum 34:888–893PubMedCrossRefGoogle Scholar
  47. 47.
    Pruijn GJM, Wingens PAETM, Peters ALM, Thijssen JPH & van Venrooij WJ (1993) Biochim Biophys Acta 1216:395–401PubMedGoogle Scholar
  48. 48.
    Ben-Chetrit E, Gandy BJ, Tan EM & Sullivan KF (1989) J Clin Invest 83:1284–1292PubMedCrossRefGoogle Scholar
  49. 49.
    Chan EKL (1994) In: Homma M (Ed) Proceedings of the 4th International Symposium on Sjögren’s Syndrome. Basis for Heterogeneity of SS-A/Ro Autoantigens. Kugler Publications, AmsterdamGoogle Scholar
  50. 50.
    Frank MB, Itoh K, Fujisaku A, Pontarotti P, Mattei MG & Neas BR (1993) Am J Hum Genet 52:183–191PubMedGoogle Scholar
  51. 50a.
    Chan EKL, Tan EM, Ward DC & Matera AG (1994) Genomics, in press.Google Scholar
  52. 51.
    Adam SA, Nakagawa T, Swanson MS, Woodruff TK & Dreyfuss G (1986) Mol Cell Biol 6:2932–2943PubMedGoogle Scholar
  53. 52.
    Kenan DJ, Query CC & Keene JD (1991) Trends Biochem Sci 16:214–220PubMedCrossRefGoogle Scholar
  54. 53.
    Scofield RH & Harley JB (1991) Proc Natl Acad Sci USA 88:3343–3347PubMedCrossRefGoogle Scholar
  55. 54.
    Bellini M, Lacroix J-C & Gall JG (1993) EMBO J 12:107–114PubMedGoogle Scholar
  56. 55.
    Isomura T, Tamiya-Koizumi K, Suzuki M, Yoshida S, Taniguchi M, Matsuyama M, Ishigaki T, Sakuma S & Takahashi M (1992) Nucleic Acids Res 20:5305–5310PubMedCrossRefGoogle Scholar
  57. 56.
    Buyon JP, Slade SG, Reveille JD, Hamel JC & Chan EKL (1994) J Immunol 152:3675–3684PubMedGoogle Scholar
  58. 57.
    Bozic B, Pruijn GJM, Rozman B & van Venrooij WJ (1993) Clin Exp Immunol 94:227–235CrossRefGoogle Scholar
  59. 58.
    Reichlin M & Reichlin MW (1989) J Autoimmun 2:359–365PubMedCrossRefGoogle Scholar
  60. 59.
    Itoh Y, Itoh K, Frank MB & Reichlin M (1992) Autoimmunity 14:89–95PubMedCrossRefGoogle Scholar
  61. 60.
    Tan EM & Chan EKL (1993) Clinical Investigator 71:327–330PubMedGoogle Scholar
  62. 61.
    Tan EM (1989) Adv Immunol 44:93–151PubMedCrossRefGoogle Scholar
  63. 62.
    Tan EM, Chan EKL, Sullivan KF & Rubin RL (1988) Clin Immunol Immunopathol 47:121–141PubMedCrossRefGoogle Scholar
  64. 63.
    Mayet WJ, Bachmann M, Pfeifer K, Schroder HC, Muller WE, Gudat W, Korting GW & Meyer zum Buschenfelde KH (1988) Eur J Clin Invest 18:465–471PubMedCrossRefGoogle Scholar
  65. 64.
    Bachmann M, Mayet WJ, Schroder HC, Pfeifer K, Meyer zum Buschenfelde KH & Muller WE (1986) Proc Natl Acad Sci USA 83:7770–7774PubMedCrossRefGoogle Scholar
  66. 65.
    Reddy BA, Etkin LD & Freemont PS (1992) Trends Biochem Sci 17:344–345PubMedCrossRefGoogle Scholar
  67. 66.
    Takahashi M, Inaguma Y, Hiai H & Hirose F (1988) Mol Cell Biol 8:1853–1856PubMedGoogle Scholar
  68. 67.
    Ricchiuti V, Briand JP, Meyer O, Isenberg D, Pruijn GJM & Muller S (1994) Clin Exp Immunol 95:397–407PubMedCrossRefGoogle Scholar
  69. 68.
    Scofield RH, Dickey WD, Jackson KW, James JA & Harley JB (1993) J Clin Immunol 11:378–388CrossRefGoogle Scholar
  70. 69.
    Barakat S, Meyer O, Torterotot F, Youinou P, Briand JP, Kahn MF & Muller S (1992) Clin Exp Immunol 89:38–45PubMedCrossRefGoogle Scholar
  71. 70.
    Wahren M, Ruden U, Andersson B, Ringertz NR & Pettersson I (1992) J Autoimmun 5:319–332PubMedCrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  • Ger J. M. Pruijn
    • 1
  1. 1.Department of BiochemistryUniversity of NijmegenHB NijmegenThe Netherlands

Personalised recommendations